Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Cholangiocarcinoma 3Jaundice 2Bile Duct Neoplasms 2Pancreatic Cancer Metastatic to Liver 1Neoplasms 1Klatskin Tumor 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Fistula 1Disease 1Cholestasis 1Biliary Tract Neoplasms 1

Interventions

Surveys and Questionnaires 9Standard of Care 5Endoscopic Mucosal Resection 5Educational Status 5Blood Specimen Collection 5Diet Therapy 3Referral and Consultation 2Quality of Life 2Practice Guidelines as Topic 2Palliative Care 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Control Groups 2Aprepitant 2Acceptance and Commitment Therapy 2vandetanib 1fosaprepitant 1dolasetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Weights and Measures 1Tomography, X-Ray Computed 1Therapeutics 1Surgical Instruments 1Sunitinib 1Sorafenib 1Sampling Studies 1Restraint, Physical 1Remote Patient Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gastrointestinal Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT05994521 2024-10-01

INTERCEPT

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Recruiting
110 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡